Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G P Herzig

Showing results (61-70 of 89) with videos related to

Pageof 9
Sort By:
Blood|June 1, 1985
High-dose cytosine arabinoside and daunorubicin as consolidation therapy for acute nonlymphocytic leukemia in first remission: a pilot studyS N Wolff, J Marion, R S Stein, et al.
Blood|March 1, 1995
High-dose etoposide, cyclophosphamide, and total body irradiation with allogeneic bone marrow transplantation for patients with acute myeloid leukemia in untreated first relapse: a study by the North American Marrow Transplant GroupR A Brown, S N Wolff, J W Fay, et al.
Transplantation Proceedings|March 1, 1971
HL-A and mixed leukocyte culture matched allogeneic bone marrow transplantation in patients with acute leukemiaR G Graw, B G Leventhal, R A Yankee, et al.
Leukemia & Lymphoma|July 1, 1996
High-dose etoposide, cyclophosphamide and total body irradiation with allogeneic bone marrow transplantation for resistant acute myeloid leukemia: a study by the North American Marrow Transplant GroupR A Brown, S N Wolff, J W Fay, et al.
Cancer|March 1, 1978
Prolonged complete remission following high dose chemotherapy of Burkitt's lymphoma in relapseF R Appelbaum, A B Deisseroth, R G Graw, et al.
Cancer Research|January 15, 1994
Molecular rearrangement of the ALL-1 gene in acute myeloid leukemia without cytogenetic evidence of 11q23 chromosomal translocationsM A Caligiuri, S A Schichman, M P Strout, et al.
Lancet (London, England)|November 21, 1970
Graft-versus-host reaction complicating HL-A matched bone-marrow transplantationR G Graw, G N Rogentine, B G Leventhal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1987
Cerebellar toxicity with high-dose cytosine arabinosideR H Herzig, J D Hines, G P Herzig, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1989
High-dose cytarabine and daunorubicin as consolidation therapy for acute myeloid leukemia in first remission: long-term follow-up and resultsS N Wolff, R H Herzig, J W Fay, et al.
Cancer|November 15, 1983
Intensive 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), NSC #4366650 and cryopreserved autologous marrow transplantation for refractory cancer. A phase I-II studyG L Phillips, J W Fay, G P Herzig, et al.
Pageof 9

Showing results (61-70 of 89) with videos related to

Sort By:
Pageof 9
Blood|June 1, 1985
High-dose cytosine arabinoside and daunorubicin as consolidation therapy for acute nonlymphocytic leukemia in first remission: a pilot studyS N Wolff, J Marion, R S Stein, et al.
Blood|March 1, 1995
High-dose etoposide, cyclophosphamide, and total body irradiation with allogeneic bone marrow transplantation for patients with acute myeloid leukemia in untreated first relapse: a study by the North American Marrow Transplant GroupR A Brown, S N Wolff, J W Fay, et al.
Transplantation Proceedings|March 1, 1971
HL-A and mixed leukocyte culture matched allogeneic bone marrow transplantation in patients with acute leukemiaR G Graw, B G Leventhal, R A Yankee, et al.
Leukemia & Lymphoma|July 1, 1996
High-dose etoposide, cyclophosphamide and total body irradiation with allogeneic bone marrow transplantation for resistant acute myeloid leukemia: a study by the North American Marrow Transplant GroupR A Brown, S N Wolff, J W Fay, et al.
Cancer|March 1, 1978
Prolonged complete remission following high dose chemotherapy of Burkitt's lymphoma in relapseF R Appelbaum, A B Deisseroth, R G Graw, et al.
Cancer Research|January 15, 1994
Molecular rearrangement of the ALL-1 gene in acute myeloid leukemia without cytogenetic evidence of 11q23 chromosomal translocationsM A Caligiuri, S A Schichman, M P Strout, et al.
Lancet (London, England)|November 21, 1970
Graft-versus-host reaction complicating HL-A matched bone-marrow transplantationR G Graw, G N Rogentine, B G Leventhal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1987
Cerebellar toxicity with high-dose cytosine arabinosideR H Herzig, J D Hines, G P Herzig, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1989
High-dose cytarabine and daunorubicin as consolidation therapy for acute myeloid leukemia in first remission: long-term follow-up and resultsS N Wolff, R H Herzig, J W Fay, et al.
Cancer|November 15, 1983
Intensive 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), NSC #4366650 and cryopreserved autologous marrow transplantation for refractory cancer. A phase I-II studyG L Phillips, J W Fay, G P Herzig, et al.
Pageof 9